Resmed (RSMDF) Current Leases (2019 - 2026)

Resmed (RSMDF) has reported Current Leases for 8 consecutive years, with $29.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases fell 4.47% year-over-year to $29.1 million; the trailing twelve-month figure through Jun 2026 stood at $29.1 million (down 4.47% YoY), and the FY2026 full-year result was $29.1 million, down 4.47% from the prior year.
• Current Leases steadied at $29.1 million in Q2 2026 per RSMDF's latest filing, from $29.2 million in the prior quarter.
• Across five years, Current Leases topped out at $30.5 million in Q2 2025 and bottomed at $21.1 million in Q3 2022.
• Historically, Current Leases has averaged $25.7 million across 5 years, with a median of $24.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Current Leases declined 8.04% in 2022, then gained 29.75% in 2024.
• Over 5 years, Current Leases stood at $22.4 million in 2022, then advanced by 7.26% to $24.1 million in 2023, then increased by 15.61% to $27.8 million in 2024, then advanced by 7.0% to $29.8 million in 2025, then fell by 2.08% to $29.1 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $29.1 million, $29.2 million, and $29.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.